Hybrid Membrane-Camouflaged Osimertinib-Loaded Hollow Mesoporous Prussian Blue Nanoparticles for Synergistic Photothermal/Targeted Therapy of Non-Small Cell Lung Cancer
ACS Applied Nano Materials · 12.06.2026 · 9 (23) · 10691-10702
DOI: 10.1021/acsanm.6c01021 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 02.06.2026. Verfasst von Lanxiang Wu und 5 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Natural Science Foundation of Chongqing Municipality
- Shanghai Key Laboratory of Female Reproductive Endocrine-Related Diseases
Zitieren
APA
Wu, L., Mo, W., Huang, Y., Zhou, X., Zhang, Y., & Wen, C. (2026). Hybrid Membrane-Camouflaged Osimertinib-Loaded Hollow Mesoporous Prussian Blue Nanoparticles for Synergistic Photothermal/Targeted Therapy of Non-Small Cell Lung Cancer. ACS Applied Nano Materials, 9(23), 10691-10702. https://doi.org/10.1021/acsanm.6c01021
Vancouver
Wu L, Mo W, Huang Y, Zhou X, Zhang Y, Wen C. Hybrid Membrane-Camouflaged Osimertinib-Loaded Hollow Mesoporous Prussian Blue Nanoparticles for Synergistic Photothermal/Targeted Therapy of Non-Small Cell Lung Cancer. ACS Applied Nano Materials. 2026;9(23):10691-10702. doi:10.1021/acsanm.6c01021
BibTeX
@article{Wu2026,
author = {Wu, Lanxiang and Mo, Wenlu and Huang, Yutang and Zhou, Xue and Zhang, Yuru and Wen, Chunjie},
title = {Hybrid Membrane-Camouflaged Osimertinib-Loaded Hollow Mesoporous Prussian Blue Nanoparticles for Synergistic Photothermal/Targeted Therapy of Non-Small Cell Lung Cancer},
journal = {ACS Applied Nano Materials},
year = {2026},
volume = {9},
number = {23},
pages = {10691--10702},
doi = {10.1021/acsanm.6c01021}
}
EUVIMED